WASHINGTON ADVOCACY GROUP

Lobbying for AMGEN INC. · Biotechnology

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · Senate · $15,000.00 income · posted Oct 14, 2025

Lobbying activity 1

Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.